Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
2025 · Nature Medicine · 22 citations
https://doi.org/10.1038/s41591-025-03658-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
343
Citations
6
h-index
6
i10-index
Gongyan Chen is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 6, co-authored 12 publications.
https://doi.org/10.1038/s41591-025-03658-y
https://doi.org/10.1007/s44178-024-00135-3
Click to start Chat